$CENN
Cenntro Inc. Stock $cenn

$cenn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000114036124016853 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.392M		$22.08M
YoY Change	-2.26%		146.93%
Cost Of Revenue	$3.378M		$19.82M
YoY Change	3.11%		109.62%
Gross Profit	$14.27K		$2.258M
YoY Change	-92.67%		-539.38%
Gross Profit Margin	0.42%		10.23%
Selling, General & Admin	$7.678M		$43.64M
YoY Change	-16.79%		-3.74%
% of Gross Profit	53801.13%		1932.35%
Research & Development	$1.728M		$8.469M
YoY Change	10.06%		33.11%
% of Gross Profit	12107.28%		375.03%
Depreciation & Amortization	$385.1K		$1.457M
YoY Change	26.17%		52.74%
% of Gross Profit	2698.79%		64.52%
Operating Expenses	$9.406M		$52.54M
YoY Change	-12.89%		3.42%
Operating Profit	-$9.392M		-$50.28M
YoY Change	-11.42%		-2.01%
Interest Expense	-$73.24K		-$402.4K
YoY Change	-114.91%		-98.98%
% of Operating Profit
Other Income/Expense, Net	$190.6K		$621.6K
YoY Change	33.12%		-109.53%
Pretax Income	-$9.260M		-$54.35M
YoY Change	-16.68%		-51.53%
Income Tax	-$30.03K		$8.988K
% Of Pretax Income
Net Earnings	-$9.230M		-$54.20M
YoY Change	-15.77%		-50.77%
Net Earnings / Revenue	-272.12%		-245.47%
Basic Earnings Per Share	-$0.30		-$1.78
Diluted Earnings Per Share	-$0.30		-$1.78
COMMON SHARES
Basic Shares Outstanding	30.83M	304.4M	30.42M
Diluted Shares Outstanding	30.83M		30.42M

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.44M	$33.60M
YoY Change	-73.39%	-78.17%
Cash & Equivalents	$20.26M	$29.38M
Short-Term Investments	$4.181M	$4.228M
Other Short-Term Assets	$869.1K	$573.6K
YoY Change	-91.76%	-94.51%
Inventory	$43.77M	$43.91M
Prepaid Expenses
Receivables	$4.577M	$6.531M
Other Receivables	$270.3K	$287.4K
Total Short-Term Assets	$94.73M	$104.9M
YoY Change	-35.63%	-48.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.20M	$20.40M
YoY Change	-35.13%	-11.87%
Goodwill	$218.0K	$223.5K
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.580M	$4.686M
YoY Change	-87.15%	-86.64%
Other Assets	$2.134M	$2.228M
YoY Change	-16.32%	-66.4%
Total Long-Term Assets	$78.30M	$80.61M
YoY Change	5.97%	24.33%
TOTAL ASSETS
Total Short-Term Assets	$94.73M	$104.9M
Total Long-Term Assets	$78.30M	$80.61M
Total Assets	$173.0M	$185.5M
YoY Change	-21.73%	-30.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.558M	$6.798M
YoY Change	126.21%	100.94%
Accrued Expenses
YoY Change
Deferred Revenue	$2.664M	$3.394M
YoY Change	0.3%	42.1%
Short-Term Debt		$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$27.24M	$29.30M
YoY Change	-9.24%	-58.29%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$33.26M	$34.37M
YoY Change	16.59%	33.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.24M	$29.30M
Total Long-Term Liabilities	$33.26M	$34.37M
Total Liabilities	$60.50M	$63.67M
YoY Change	3.35%	-33.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$283.3M	-$274.0M
YoY Change	22.74%	24.66%
Common Stock	$403.2M	$402.3M
YoY Change	1.25%	1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$112.5M	$121.9M
YoY Change
Total Liabilities & Shareholders Equity	$173.0M	$185.5M
YoY Change	-21.73%	-30.73%

Cashflow Statement

Concept	2024 Q1	2023
OPERATING ACTIVITIES
Net Income	-$9.230M	-$54.20M
YoY Change	-15.77%	-50.77%
Depreciation, Depletion And Amortization	$385.1K	$1.457M
YoY Change	26.17%	52.74%
Cash From Operating Activities	-$8.865M	-$58.46M
YoY Change	-48.94%	-15.77%
INVESTING ACTIVITIES
Capital Expenditures	$327.6K	$7.636M
YoY Change	-87.29%	-61.32%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$306.8K	-$16.39M
YoY Change	-105.58%	-71.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-48.14M
YoY Change	-100.0%	-347.45%
NET CHANGE
Cash From Operating Activities	-8.865M	-58.46M
Cash From Investing Activities	306.8K	-16.39M
Cash From Financing Activities	0.000	-48.14M
Net Change In Cash	-8.987M	-124.5M
YoY Change	-85.54%	16.56%
FREE CASH FLOW
Cash From Operating Activities	-$8.865M	-$58.46M
Capital Expenditures	$327.6K	$7.636M
Free Cash Flow	-$9.192M	-$66.09M
YoY Change	-53.9%	-25.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">(b)</td> <td style="width: auto; vertical-align: top;"> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Use of estimates</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company continually evaluates these estimates and assumptions based on the most recently available information, historical experience and various other assumptions that the Company believes to be reasonable under the circumstances. Significant accounting estimates reflected in the Company’s consolidated financial statements include, but are not limited to, estimates and judgments applied in determination of provision for doubtful accounts, lower of cost and net realizable value of inventories, impairment losses for long-lived assets and investments, goodwill, valuation allowance for deferred tax assets and fair value measurement for share-based compensation expense, convertible promissory notes and warrants. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates.</div>
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001707919
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	0
CY2022	us-gaap	Interest Income Operating Related Party Type Extensible Enumeration InterestIncomeOperatingRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InterestIncomeOperating
CY2023	us-gaap	Interest Income Operating Related Party Type Extensible Enumeration InterestIncomeOperatingRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InterestIncomeOperating
CY2023	us-gaap	Interest Expense Operating Related Party Type Extensible Enumeration InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InterestExpense
CY2022	us-gaap	Interest Expense Operating Related Party Type Extensible Enumeration InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InterestExpense
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Auditor Firm AuditorFirmId	2729
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38544
CY2023	dei	Entity Registrant Name EntityRegistrantName	CENNTRO INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	501 Okerson Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Freehold
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07728
CY2023	dei	City Area Code CityAreaCode	732
CY2023	dei	Local Phone Number LocalPhoneNumber	820-6757
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	CENN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30828795
CY2023Q2	dei	Entity Public Float EntityPublicFloat	67270474
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	GGF CPA LTD
CY2023	dei	Auditor Location AuditorLocation	Guangzhou, People's Republic of China
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29375727
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153966777
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	196170
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	130024
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	4236588
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6530801
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	565398
CY2023Q4	us-gaap	Inventory Net InventoryNet	43909564
CY2022Q4	us-gaap	Inventory Net InventoryNet	31843371
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20391150
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16138330
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	287439
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	366936
CY2023Q4	us-gaap	Assets Current AssetsCurrent	104927439
CY2022Q4	us-gaap	Assets Current AssetsCurrent	203010836
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4685984
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5325741
CY2023Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	26158474
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	29759195
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20401521
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14962591
CY2023Q4	us-gaap	Goodwill Goodwill	223494
CY2022Q4	us-gaap	Goodwill Goodwill	0
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6873781
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4563792
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20039625
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8187149
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2227672
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2039012
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	80610551
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	64837480
CY2023Q4	us-gaap	Assets Assets	185537990
CY2022Q4	us-gaap	Assets Assets	267848316
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6797852
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3383021
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4263887
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5048641
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3394044
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2388480
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4741599
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1313334
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9956000
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	57372827
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	26669
CY2023Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	108717
CY2022Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	26533
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10468
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	716372
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29299236
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70249208
CY2023Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	230063
CY2022Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	0
CY2023Q4	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	228086
CY2022Q4	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	0
CY2023Q4	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	1929733
CY2022Q4	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	497484
CY2023Q4	cenn	Derivative Liabilities Investor Warrants Noncurrent DerivativeLiabilitiesInvestorWarrantsNoncurrent	12189508
CY2022Q4	cenn	Derivative Liabilities Investor Warrants Noncurrent DerivativeLiabilitiesInvestorWarrantsNoncurrent	14334104
CY2023Q4	cenn	Derivative Liabilities Placement Agent Warrants Noncurrent DerivativeLiabilitiesPlacementAgentWarrantsNoncurrent	3456578
CY2022Q4	cenn	Derivative Liabilities Placement Agent Warrants Noncurrent DerivativeLiabilitiesPlacementAgentWarrantsNoncurrent	3456404
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16339619
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7421582
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	34373587
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	25709574
CY2023Q4	us-gaap	Liabilities Liabilities	63672823
CY2022Q4	us-gaap	Liabilities Liabilities	95958782
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30828778
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30828778
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30084200
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30084200
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	402337393
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	397497817
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274023501
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-219824176
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6444485
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5306972
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	121869407
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	172366669
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-4240
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-477135
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	121865167
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	171889534
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185537990
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	267848316
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22079905
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8941835
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	621633
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-924867
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54351767
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19821645
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9455805
CY2023	us-gaap	Gross Profit GrossProfit	2258260
CY2022	us-gaap	Gross Profit GrossProfit	-513970
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7868773
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6525255
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35768786
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32822709
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8469241
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6362770
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5986308
CY2023	cenn	Impairment Of Right Of Use Assets ImpairmentOfRightOfUseAssets	0
CY2022	cenn	Impairment Of Right Of Use Assets ImpairmentOfRightOfUseAssets	371695
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2995440
CY2023	cenn	Reverse Of Deferred Tax Liabilities ReverseOfDeferredTaxLiabilities	0
CY2022	cenn	Reverse Of Deferred Tax Liabilities ReverseOfDeferredTaxLiabilities	898632
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	431319
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	550402
CY2023	us-gaap	Operating Expenses OperatingExpenses	52538119
CY2022	us-gaap	Operating Expenses OperatingExpenses	54715947
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-50279859
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-55229917
CY2023	us-gaap	Interest Expense InterestExpense	-402414
CY2022	us-gaap	Interest Expense InterestExpense	844231
CY2023	cenn	Gain Loss On Redemption Of Convertible Promissory Notes GainLossOnRedemptionOfConvertiblePromissoryNotes	12507
CY2022	cenn	Gain Loss On Redemption Of Convertible Promissory Notes GainLossOnRedemptionOfConvertiblePromissoryNotes	-7435
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1377760
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12651
CY2023	cenn	Change In Fair Value Of Convertible Promissory Notes And Derivative Liability ChangeInFairValueOfConvertiblePromissoryNotesAndDerivativeLiability	75341
CY2022	cenn	Change In Fair Value Of Convertible Promissory Notes And Derivative Liability ChangeInFairValueOfConvertiblePromissoryNotesAndDerivativeLiability	-37774928
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-2600721
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-240805
CY2023	cenn	Convertible Promissory Notes Issuance Costs ConvertiblePromissoryNotesIssuanceCosts	0
CY2022	cenn	Convertible Promissory Notes Issuance Costs ConvertiblePromissoryNotesIssuanceCosts	5589336
CY2023	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	848781
CY2022	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	409207
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11111886
CY2023	cenn	Loss Income From Acquisition Of Equity Interests LossIncomeFromAcquisitionOfEquityInterests	136302
CY2022	cenn	Loss Income From Acquisition Of Equity Interests LossIncomeFromAcquisitionOfEquityInterests	0
CY2023	cenn	Gain Loss On Exercise Of Warrants GainLossOnExerciseOfWarrants	-228903
CY2022	cenn	Gain Loss On Exercise Of Warrants GainLossOnExerciseOfWarrants	0
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	8664
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8988
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-112145263
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2995440
CY2023	cenn	Reverse Of Deferred Tax Liabilities ReverseOfDeferredTaxLiabilities	0
CY2023	us-gaap	Profit Loss ProfitLoss	-54360755
CY2022	us-gaap	Profit Loss ProfitLoss	-112145263
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-161430
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2057022
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-54199325
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-110088241
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1162080
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3889706
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-55522835
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-116034969
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-185997
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2032455
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-55336838
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-114002514
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30424686
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30424686
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26332324
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26332324
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.78
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.78
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.18
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.18
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	263773305
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4031629
CY2022	cenn	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	18549864
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14385
CY2022	us-gaap	Profit Loss ProfitLoss	-112145263
CY2022	cenn	Stock Issued During Period Value Acquisition Of Equity Interest StockIssuedDuringPeriodValueAcquisitionOfEquityInterest	1555320
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3889706
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	171889534
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5230273
CY2023	us-gaap	Profit Loss ProfitLoss	-54360755
CY2023	cenn	Stock Issued During Period Value Acquisition Of Equity Interest StockIssuedDuringPeriodValueAcquisitionOfEquityInterest	-1899990
CY2023	cenn	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2168185
CY2023	cenn	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	0
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1162080
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	121865167
CY2023	us-gaap	Profit Loss ProfitLoss	-54360755
CY2022	us-gaap	Profit Loss ProfitLoss	-112145263
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1670980
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	953872
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4495244
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1616853
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	431319
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	550402
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11111886
CY2022	cenn	Reverse Of Deferred Tax Liabilities ReverseOfDeferredTaxLiabilities	898632
CY2023	cenn	Impairment Of Right Of Use Assets ImpairmentOfRightOfUseAssets	0
CY2022	cenn	Impairment Of Right Of Use Assets ImpairmentOfRightOfUseAssets	371695
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	658622
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	2155400
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5986308
CY2023	cenn	Convertible Promissory Notes Issuance Costs ConvertiblePromissoryNotesIssuanceCosts	0
CY2022	cenn	Convertible Promissory Notes Issuance Costs ConvertiblePromissoryNotesIssuanceCosts	5589336
CY2023	cenn	Gain Loss On Redemption Of Convertible Promissory Notes GainLossOnRedemptionOfConvertiblePromissoryNotes	12507
CY2022	cenn	Gain Loss On Redemption Of Convertible Promissory Notes GainLossOnRedemptionOfConvertiblePromissoryNotes	-7435
CY2023	cenn	Gain Loss On Exercise Of Warrants GainLossOnExerciseOfWarrants	-228903
CY2022	cenn	Gain Loss On Exercise Of Warrants GainLossOnExerciseOfWarrants	0
CY2023	cenn	Change In Fair Value Of Convertible Promissory Notes And Derivative Liability ChangeInFairValueOfConvertiblePromissoryNotesAndDerivativeLiability	75341
CY2022	cenn	Change In Fair Value Of Convertible Promissory Notes And Derivative Liability ChangeInFairValueOfConvertiblePromissoryNotesAndDerivativeLiability	-37774928
CY2023	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-2600721
CY2022	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-240805
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1527077
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-409207
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5230273
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4031629
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-55391
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	10334
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1377760
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12651
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	22918
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	0
CY2023	cenn	Loss Income From Acquisition Of Equity Interests LossIncomeFromAcquisitionOfEquityInterests	136302
CY2022	cenn	Loss Income From Acquisition Of Equity Interests LossIncomeFromAcquisitionOfEquityInterests	0
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-15930
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5871181
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-233570
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12178463
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20483127
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4624170
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6753851
CY2023	cenn	Increase Decrease In Due From To Related Parties Current IncreaseDecreaseInDueFromToRelatedPartiesCurrent	-11799
CY2022	cenn	Increase Decrease In Due From To Related Parties Current IncreaseDecreaseInDueFromToRelatedPartiesCurrent	1190573
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3100835
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2144725
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1325504
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1358858
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2516789
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	633825
CY2023	cenn	Increase Decrease In Long Term Payable IncreaseDecreaseInLongTermPayable	0
CY2022	cenn	Increase Decrease In Long Term Payable IncreaseDecreaseInLongTermPayable	-700000
CY2023	cenn	Increase Decrease In Operating Lease Assets And Liability IncreaseDecreaseInOperatingLeaseAssetsAndLiability	-4012410
CY2022	cenn	Increase Decrease In Operating Lease Assets And Liability IncreaseDecreaseInOperatingLeaseAssetsAndLiability	-1108721
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-58457164
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69401126
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	880932
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	4256276
CY2023	cenn	Purchase Of Convertible Note PurchaseOfConvertibleNote	600000
CY2022	cenn	Purchase Of Convertible Note PurchaseOfConvertibleNote	0
CY2023	cenn	Purchase Of Wealth Management Products Purchased From Banks PurchaseOfWealthManagementProductsPurchasedFromBanks	4236740
CY2022	cenn	Purchase Of Wealth Management Products Purchased From Banks PurchaseOfWealthManagementProductsPurchasedFromBanks	0
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7636020
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3285072
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1114943
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16456355
CY2023	cenn	Payment Of Expense For Acquisition PaymentOfExpenseForAcquisition	0
CY2022	cenn	Payment Of Expense For Acquisition PaymentOfExpenseForAcquisition	348987
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	30000000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3661
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	309
CY2023	cenn	Payments To Loans Provided To Third Parties PaymentsToLoansProvidedToThirdParties	0
CY2022	cenn	Payments To Loans Provided To Third Parties PaymentsToLoansProvidedToThirdParties	1323671
CY2023	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	0
CY2022	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	1280672
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16388156
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56883397
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1726614
CY2023	cenn	Repayment Of Loans To Third Parties RepaymentOfLoansToThirdParties	0
CY2022	cenn	Repayment Of Loans To Third Parties RepaymentOfLoansToThirdParties	1113692
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	601476
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	13228101
CY2023	cenn	Payments For Capital PaymentsForCapital	0
CY2022	cenn	Payments For Capital PaymentsForCapital	13930000
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	54069000
CY2023	cenn	Payments For Redemption Of Convertible Promissory Notes PaymentsForRedemptionOfConvertiblePromissoryNotes	47534119
CY2022	cenn	Payments For Redemption Of Convertible Promissory Notes PaymentsForRedemptionOfConvertiblePromissoryNotes	3727500
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14386
CY2023	cenn	Payment For Expense Of Reverse Recapitalization PaymentForExpenseOfReverseRecapitalization	0
CY2022	cenn	Payment For Expense Of Reverse Recapitalization PaymentForExpenseOfReverseRecapitalization	904843
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-48135595
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19452636
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1543989
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-736274
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22079905
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8941835
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	464636
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1105076
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-124524904
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-107568161
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154096801
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	261664962
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29571897
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154096801
CY2023	cenn	Interest Paid Refunded InterestPaidRefunded	1468397
CY2022	cenn	Interest Paid Refunded InterestPaidRefunded	369410
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4797
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
CY2023	cenn	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	2168185
CY2022	cenn	Cashless Exercise Of Warrants CashlessExerciseOfWarrants	18549864
CY2023	cenn	Non Cash Capital Injection NonCashCapitalInjection	250000
CY2022	cenn	Non Cash Capital Injection NonCashCapitalInjection	0
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1000000
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0
CY2023	cenn	Non Cash Recognition Of New Leases NonCashRecognitionOfNewLeases	14947878
CY2022	cenn	Non Cash Recognition Of New Leases NonCashRecognitionOfNewLeases	0
CY2023	cenn	Other Than Temporary Impairment Losses Debt Securities Available For Sale OtherThanTemporaryImpairmentLossesDebtSecuritiesAvailableForSale	0
CY2022	cenn	Other Than Temporary Impairment Losses Debt Securities Available For Sale OtherThanTemporaryImpairmentLossesDebtSecuritiesAvailableForSale	0
CY2023	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<div><span style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div> <div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;"> <tr style="vertical-align: top;"> <td style="text-align: right; vertical-align: top; width: 18pt;"> <div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left;"><span style="font-style: italic; font-weight: bold;">(i)</span></div> </td> <td style="text-align: left; vertical-align: top; width: auto;"> <div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold; font-style: italic;">Cross-currency swap</span><br/> </div> </td> </tr> </table> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The Company used cross-currency swap contracts to manage its exposures to movements in foreign exchange rates primarily related to the RMB or Renminbi. The use of these cross-currency swap modifies the Company’s exposure to these risks with the goal of reducing the risk or cost to the Company. The Company does not use derivatives for trading purposes and is not a party to leveraged derivative contracts.</div> <div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Depending on the nature of the underlying risk being hedged, these cross-currency swap are accounted for either as cash flow, net investment or mark to market hedges against changes in the value of the hedged item. Derivatives are recorded in the Consolidated Balance Sheets at fair value. The fair value is based upon either market quotes for actively traded instruments or independent bids for nonexchange traded instruments. The accounting for changes in fair value of a derivative instrument depends on whether the instrument has been designated and qualifies as part of a hedging relationship. The Company determines whether a derivative instrument meets the criteria for cash flow or net investment hedge accounting treatment on the date the derivative is executed. Derivatives accounted for as mark to market hedges are not designated as hedges for accounting purposes.</div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <span style="font-style: italic;">Economic Hedges</span><br/> </div> <div><span style="font-style: italic;"> </span><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">A derivative instrument whose change in fair value is used to hedge against changes in the value of a hedged item, but which is not designated as a hedge under ASC815 “Derivative Instruments and Hedging Activities”, is accounted for as an economic hedge. These derivatives are recorded at fair value in the Consolidated Balance Sheets when the hedged item is recorded as an asset or liability and then are revalued each accounting period. Changes in the fair value of derivatives accounted for as economic hedges are reported in the “Gain from cross-currency swaps” lines under “Other expense” in the Consolidated Statements of Operations. Cash flows from derivatives not designated as hedges are classified as cash flows from operating activities in the Consolidated Statements of Cash Flows. For the year ended December 31, 2023, all of the cross-currency swap contracts were accounted for as economic hedges.</div>
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	431319
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3917537
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11111886
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22079905
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8941835
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6530801
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	565398
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3394044
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2388480
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q4	cenn	Long Lived Assets LongLivedAssets	47314927
CY2022Q4	cenn	Long Lived Assets LongLivedAssets	27713532
CY2023Q4	us-gaap	Goodwill Goodwill	223494
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	4227947
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	8641
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	4236588
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	8443069
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2526432
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1912268
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1961034
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6530801
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	565398
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1961034
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1475983
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1394591
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	108288
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	922632
CY2023	cenn	Accounts Receivable Allowance For Credit Loss Foreign Exchanges AccountsReceivableAllowanceForCreditLossForeignExchanges	59522
CY2022	cenn	Accounts Receivable Allowance For Credit Loss Foreign Exchanges AccountsReceivableAllowanceForCreditLossForeignExchanges	13092
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1912268
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1961034
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10209773
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	9311419
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1494441
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	290220
CY2023Q4	cenn	Inventory Goods In Transit InventoryGoodsInTransit	3774310
CY2022Q4	cenn	Inventory Goods In Transit InventoryGoodsInTransit	2364136
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	28431040
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19877596
CY2023Q4	us-gaap	Inventory Net InventoryNet	43909564
CY2022Q4	us-gaap	Inventory Net InventoryNet	31843371
CY2023	cenn	Impairment Loss Recognized For Inventory ImpairmentLossRecognizedForInventory	658622
CY2022	cenn	Impairment Loss Recognized For Inventory ImpairmentLossRecognizedForInventory	2155400
CY2023Q4	us-gaap	Supplies Supplies	12579554
CY2022Q4	us-gaap	Supplies Supplies	9877337
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	6238040
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	4097162
CY2023Q4	cenn	Receivable From Third Party Current ReceivableFromThirdPartyCurrent	1000000
CY2022Q4	cenn	Receivable From Third Party Current ReceivableFromThirdPartyCurrent	0
CY2023Q4	cenn	Loan To Related Party Current LoanToRelatedPartyCurrent	0
CY2022Q4	cenn	Loan To Related Party Current LoanToRelatedPartyCurrent	1044181
CY2023Q4	cenn	Receivable From Third Parties Current ReceivableFromThirdPartiesCurrent	0
CY2022Q4	cenn	Receivable From Third Parties Current ReceivableFromThirdPartiesCurrent	678887
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	573556
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	440763
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20391150
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16138330
CY2023Q4	cenn	Equity Method Investments With Readily Determinable Fair Value Amount EquityMethodInvestmentsWithReadilyDeterminableFairValueAmount	2624272
CY2022Q4	cenn	Equity Method Investments With Readily Determinable Fair Value Amount EquityMethodInvestmentsWithReadilyDeterminableFairValueAmount	5325741
CY2023Q4	cenn	Equity Method Investments Without Readily Determinable Fair Value Amount EquityMethodInvestmentsWithoutReadilyDeterminableFairValueAmount	1450000
CY2022Q4	cenn	Equity Method Investments Without Readily Determinable Fair Value Amount EquityMethodInvestmentsWithoutReadilyDeterminableFairValueAmount	0
CY2023Q4	cenn	Number Of Equity Investments NumberOfEquityInvestments	2
CY2023Q4	us-gaap	Deposit Assets DepositAssets	1071974
CY2022Q4	us-gaap	Deposit Assets DepositAssets	758038
CY2023Q4	cenn	Long Term Prepayment LongTermPrepayment	952615
CY2022Q4	cenn	Long Term Prepayment LongTermPrepayment	1280974
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2227672
CY2023Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	26158474
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	29759195
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25079045
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18368453
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4677524
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3405862
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20401521
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14962591
CY2023	us-gaap	Depreciation Depreciation	1456984
CY2022	us-gaap	Depreciation Depreciation	907739
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	431319
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	550402
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7246655
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4725288
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	372874
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	161496
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6873781
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4563792
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	213996
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46133
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2995440
CY2023Q4	cenn	Loan To Related Party Noncurrent LoanToRelatedPartyNoncurrent	0
CY2022Q4	cenn	Loan To Related Party Noncurrent LoanToRelatedPartyNoncurrent	4591717
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	203083
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	0
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	6630729
CY2023Q4	cenn	Provision For Loan To Receivable From Related Parties ProvisionForLoanToReceivableFromRelatedParties	0
CY2022Q4	cenn	Provision For Loan To Receivable From Related Parties ProvisionForLoanToReceivableFromRelatedParties	4591717
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2227672
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2039012
CY2023Q4	cenn	Percentage Of Mold Development Fee PercentageOfMoldDevelopmentFee	0.50
CY2023	cenn	Purchased Prepaid Insurance Policy Period PurchasedPrepaidInsurancePolicyPeriod	P6Y
CY2023Q4	cenn	Accrued Litigation Compensation Current AccruedLitigationCompensationCurrent	1773007
CY2022Q4	cenn	Accrued Litigation Compensation Current AccruedLitigationCompensationCurrent	1590484
CY2023Q4	cenn	Accrued Return Liability Current AccruedReturnLiabilityCurrent	961914
CY2022Q4	cenn	Accrued Return Liability Current AccruedReturnLiabilityCurrent	797969
CY2023Q4	cenn	Other Taxes Payable Current OtherTaxesPayableCurrent	732685
CY2022Q4	cenn	Other Taxes Payable Current OtherTaxesPayableCurrent	118469
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	621605
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	452904
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	36505
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	919525
CY2023Q4	cenn	Accounts Payable For Purchasing The Factory Current AccountsPayableForPurchasingTheFactoryCurrent	0
CY2022Q4	cenn	Accounts Payable For Purchasing The Factory Current AccountsPayableForPurchasingTheFactoryCurrent	588645
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	383250
CY2023Q4	cenn	Credit Card Payable Current CreditCardPayableCurrent	106650
CY2022Q4	cenn	Credit Card Payable Current CreditCardPayableCurrent	22908
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31521
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	174487
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4263887
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5048641
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8988
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24919
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15931
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8988
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54351767
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-112145263
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54351767
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-112145263
CY2023	cenn	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Percent Tax Reconciliation Not Required EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentTaxReconciliationNotRequired	0.25
CY2022	cenn	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Percent Tax Reconciliation Not Required EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentTaxReconciliationNotRequired	0.25
CY2023	cenn	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Amount Tax Reconciliation Not Required EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateAmountTaxReconciliationNotRequired	-13587942
CY2022	cenn	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Amount Tax Reconciliation Not Required EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateAmountTaxReconciliationNotRequired	-28036316
CY2023	cenn	Effective Income Tax Rate Reconciliation Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAmount	1535761
CY2022	cenn	Effective Income Tax Rate Reconciliation Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAmount	161592
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	123766
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2255963
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	569327
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1069009
CY2023	cenn	Effective Income Tax Rate Reconciliation Deduction Research And Development Amount EffectiveIncomeTaxRateReconciliationDeductionResearchAndDevelopmentAmount	1261231
CY2022	cenn	Effective Income Tax Rate Reconciliation Deduction Research And Development Amount EffectiveIncomeTaxRateReconciliationDeductionResearchAndDevelopmentAmount	568446
CY2023	cenn	Effective Income Tax Rate Reconciliation Fair Value Change Of Warrant Liability EffectiveIncomeTaxRateReconciliationFairValueChangeOfWarrantLiability	60799
CY2022	cenn	Effective Income Tax Rate Reconciliation Fair Value Change Of Warrant Liability EffectiveIncomeTaxRateReconciliationFairValueChangeOfWarrantLiability	3912074
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	2777972
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	12584439
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	22940078
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24919
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2023	cenn	Effective Income Tax Rate Reconciliation Percent Tax Reconciliation Not Required EffectiveIncomeTaxRateReconciliationPercentTaxReconciliationNotRequired	0
CY2022	cenn	Effective Income Tax Rate Reconciliation Percent Tax Reconciliation Not Required EffectiveIncomeTaxRateReconciliationPercentTaxReconciliationNotRequired	0
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	3561625
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	3532162
CY2023Q4	cenn	Deferred Tax Assets Change In Fair Value Of Equity Securities Fvni DeferredTaxAssetsChangeInFairValueOfEquitySecuritiesFVNI	-3885519
CY2022Q4	cenn	Deferred Tax Assets Change In Fair Value Of Equity Securities Fvni DeferredTaxAssetsChangeInFairValueOfEquitySecuritiesFVNI	912340
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	943938
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	369687
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	42229598
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28818841
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	42849642
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33633030
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42849642
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33633030
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	228086
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	228086
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	228086
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33633030
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14659415
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12584439
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	22940078
CY2023	cenn	Valuation Allowance Deferred Tax Asset Expire Of Net Operating Loss Amount ValuationAllowanceDeferredTaxAssetExpireOfNetOperatingLossAmount	-3165660
CY2022	cenn	Valuation Allowance Deferred Tax Asset Expire Of Net Operating Loss Amount ValuationAllowanceDeferredTaxAssetExpireOfNetOperatingLossAmount	-1318979
CY2023	cenn	Valuation Allowance Deferred Tax Asset Change In Tax Rate Amount ValuationAllowanceDeferredTaxAssetChangeInTaxRateAmount	96387
CY2022	cenn	Valuation Allowance Deferred Tax Asset Change In Tax Rate Amount ValuationAllowanceDeferredTaxAssetChangeInTaxRateAmount	-91423
CY2023	cenn	Valuation Allowance Deferred Tax Asset Exchange Rate Effect Amount ValuationAllowanceDeferredTaxAssetExchangeRateEffectAmount	-298554
CY2022	cenn	Valuation Allowance Deferred Tax Asset Exchange Rate Effect Amount ValuationAllowanceDeferredTaxAssetExchangeRateEffectAmount	-2556061
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42849642
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33633030
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	4745560
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1616853
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	809894
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	238386
CY2023	us-gaap	Lease Cost LeaseCost	5555454
CY2022	us-gaap	Lease Cost LeaseCost	1855239
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	4012410
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1108721
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M17D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y4M9D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0633
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0427
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4908465
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4127389
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4180335
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4221505
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2176965
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5784794
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25399453
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4318235
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	21081218
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4741599
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16339619
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	24733336
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.61
CY2023	cenn	Warrants Exercisable Issuance Term WarrantsExercisableIssuanceTerm	P5Y
CY2023	cenn	Number Of Warrants NumberOfWarrants	2
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5230272
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4031629
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8734833
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M28D
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30084200
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30084200
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30828778
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30828778
CY2023	cenn	Number Of Votes Entitled For Each Share Of Ordinary Share NumberOfVotesEntitledForEachShareOfOrdinaryShare	1
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-54199325
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-110088241
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30424686
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30424686
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26332324
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26332324
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.78
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.78
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.18
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.18
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022Q3	cenn	Number Of European Union Trademarks Cancellation Request Filed NumberOfEuropeanUnionTrademarksCancellationRequestFiled	2
CY2023Q4	cenn	Number Of European Union Trademarks Cancelled NumberOfEuropeanUnionTrademarksCancelled	2
CY2022Q3	cenn	Number Of Complaint Causes In Contract And Tort Against Defendants NumberOfComplaintCausesInContractAndTortAgainstDefendants	11
CY2022Q3	cenn	Number Of Contract Claims NumberOfContractClaims	4
CY2022Q3	cenn	Number Of Tort Claims NumberOfTortClaims	7
CY2022Q3	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	19000000
CY2023	cenn	Period To Amend Complaint PeriodToAmendComplaint	P30D
CY2023Q4	cenn	Number Of Civil Litigation Cases Withdrawn NumberOfCivilLitigationCasesWithdrawn	2
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	287439
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	366936
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10468
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	716372
CY2023	us-gaap	Other Income OtherIncome	26746

Files In Submission

Name	View Source	Status
0001140361-24-016853-index-headers.html	Edgar Link	pending
0001140361-24-016853-index.html	Edgar Link	pending
0001140361-24-016853.txt	Edgar Link	pending
0001140361-24-016853-xbrl.zip	Edgar Link	pending
cenn-20231231.xsd	Edgar Link	pending
ef20015317_10k.htm	Edgar Link	pending
ef20015317_ex10-7.htm	Edgar Link	pending
ef20015317_ex10-8.htm	Edgar Link	pending
ef20015317_ex19.htm	Edgar Link	pending
ef20015317_ex21-1.htm	Edgar Link	pending
ef20015317_ex31-1.htm	Edgar Link	pending
ef20015317_ex31-2.htm	Edgar Link	pending
ef20015317_ex32-1.htm	Edgar Link	pending
ef20015317_ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image00002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
cenn-20231231_cal.xml	Edgar Link	unprocessable
cenn-20231231_def.xml	Edgar Link	unprocessable
cenn-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ef20015317_10k_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cenn-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CENN
Cenntro Inc. Stock $cenn

2024 Q1 Form 10-K Financial Statement

#000114036124016853 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CENN Cenntro Inc. Stock $cenn

2024 Q1 Form 10-K Financial Statement

#000114036124016853 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CENN
Cenntro Inc. Stock $cenn